Global Vascular Co., Ltd.
PrivateLast Round
Series B
Jun 30, 2025
Est. Valuation
$31.84M
Total Funding Raised
$16.72M
Company Overview
Global Vascular Co., Ltd. is a medical device company that develops a drug-eluting stent delivery system for the treatment of lower limb artery disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Global Vascular Co., Ltd. Comparables
Compare Global Vascular Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R3 Vascular Inc. | 85% | |
| REVA Medical | 77% | |
| Cortex, Inc. | 76% |
Global Vascular Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 30, 2025 | ||||
| Series A | Dec 5, 2023 | ||||
| Seed | May 9, 2023 |
Key People
Founding team and executive leadership
Global Vascular Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Series B |
| Diamond Medino Capital | Series B, Series A, Seed |
| Tokyo University of Science Investment Management | Series A |
| Tokyo University of Science Innovation Capital | Series B, Series A |
| Mitsui Sumitomo Insurance | Series B |
| Mitsubishi UFJ Capital | Series B, Series A |
| Fast Track Initiative | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 30% MoM.
- Jun 30, 2025
$7M round with Sumitomo Mitsui Trust Bank and Diamond Medino Capital.
Global Vascular Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Global Vascular Co., Ltd.'s valuation, stock price, and market status.
Is Global Vascular Co., Ltd. a public or private company?
Global Vascular Co., Ltd. is a private company.
What is the current stock price of Global Vascular Co., Ltd.?
Global Vascular Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Global Vascular Co., Ltd. worth (valuation)?
Global Vascular Co., Ltd.'s valuation is estimated at $31.8M based on funding round data.
Can I buy Global Vascular Co., Ltd. stock?
Global Vascular Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Global Vascular Co., Ltd.'s last funding round?
Global Vascular Co., Ltd.'s most recent funding round was Series B on December 5, 2023.
Who are the main investors in Global Vascular Co., Ltd.?
Key investors in Global Vascular Co., Ltd. include Diamond Medino Capital.
Will Global Vascular Co., Ltd. IPO soon?
No public IPO plans have been announced for Global Vascular Co., Ltd..
How can I track Global Vascular Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Global Vascular Co., Ltd.'s secondary market activity and sign up for updates.